Manhattan Associates (MANH) EBITDA (2010 - 2026)

Manhattan Associates (MANH) has 17 years of EBITDA data on file, last reported at $64.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 2.79% year-over-year to $64.9 million; the trailing twelve-month figure through Mar 2026 stood at $281.6 million (up 5.4% YoY), and the FY2025 full-year result was $279.8 million, up 6.96% from the prior year.
• EBITDA fell to $64.9 million in Q1 2026, from $67.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $75.8 million in Q3 2025 to a low of $34.0 million in Q1 2022.
• A 5-year average of $57.0 million and a median of $58.9 million in 2023 frame the typical range for EBITDA.
• Peak annual rise in EBITDA reached 64.7% in 2022, while the deepest fall reached 13.29% in 2022.
• Tracing MANH's EBITDA over 5 years: stood at $44.7 million in 2022, then jumped by 31.67% to $58.9 million in 2023, then rose by 3.1% to $60.7 million in 2024, then advanced by 10.42% to $67.0 million in 2025, then dropped by 3.1% to $64.9 million in 2026.
• Business Quant data shows MANH's EBITDA at $64.9 million in Q1 2026, $67.0 million in Q4 2025, and $75.8 million in Q3 2025.